Recent

% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. Message Board

  • rchites rchites Nov 18, 2013 9:58 AM Flag

    50% short

    ARE U KIDDING ME! 40% institutionally owned! A number of research firms have recently commented on SNTA. Analysts at Jefferies Group cut their price target on shares of Synta Pharmaceuticals Corp. from $20.00 to $19.00 in a research note to investors on Tuesday, November 5th. They now have a “buy” rating on the stock. Separately, analysts at BMO Capital Markets cut their price target on shares of Synta Pharmaceuticals Corp. from $9.00 to $5.00 in a research note to investors on Tuesday, November 5th. Finally, analysts at MLV Capital cut their price target on shares of Synta Pharmaceuticals Corp. from $16.00 to $10.00 in a research note to investors on Tuesday, November 5th. They now have a “buy” rating on the stock. Five analysts have rated the stock with a buy rating, The stock currently has an average rating of “Buy” and an average price target of $13.33. INSIDERS are buying also to make matters worsted for shorts. Happy hunting because the longs look serious here. 1.The stock is purchased by three or more insiders within one month.
    2.The stock is sold by no insiders in the month of intensive purchasing.
    3.At least two purchasers increased their holdings by more than 10%.

 
SNTA
0.343+0.072(+26.61%)Jul 22 4:00 PMEDT